Elanco Purchases Indianapolis GM Plant Launches Innovation District

Indiana Governor Mike Braun announced the sale of the former GM Stamping Plant in Indianapolis to Elanco Animal Health for $27 million, marking a transition of the site from state-owned to private hands. This transaction accelerates Elanco's plan to establish a global innovation district anchored by its new headquarters, designed to integrate research institutes, pilot-scale facilities, diagnostic labs, and animal clinical care with housing, retail, and green spaces. The State of Indiana will remain an active partner in the development through the Indiana Office of Commerce, supporting job creation, talent attraction, and long-term economic growth. Elanco CEO Jeff Simmons emphasized the importance of the state’s partnership, which allows the company to proceed with certainty and speed in developing the site. Purdue University, led by President Mung Chiang, is also a key partner, contributing expertise in animal, plant, and human health to foster One Health jobs and workforce opportunities within the district. The project aims to create a world-class innovation hub that draws companies, investment, and talent to Indiana, while maintaining a focus on progress and partnership.